CCM
AH

Cortex Capital Management’s Accretive Health AH Stock Holding History

Cortex Capital Management’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-90,000
Closed -$720K – 40
2014
Q1 		$720K Buy
+90,000
New +$797K 0.62% 28

Other funds holding AH

JRP
Jasper Ridge Partners Menlo Park, California $4.49B AUM 18.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
RMC
Regis Management Company Menlo Park, California $331M AUM 14.13% 1-Year Est. Return
BCM
Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return
ECM
EII Capital Management New York $774K AUM 22.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
MIM
Merion Investment Management Bay Harbor Islands, Florida $1.26M AUM 28.57% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
SCM
Stonebridge Capital Management Los Angeles, California $220M AUM

Cortex Capital Management's AH Position: Q2 2014 in Review

Cortex Capital Management sold out of Accretive Health (AH) in Q2 2014, closing a stake of 90,000 shares — an estimated $720K sold.

Cortex Capital Management first reported a position in AH in Q1 2014 and held it in 1 quarter. The position peaked at $720K in Q1 2014. 12 funds tracked by Wall St. Rank hold AH as of Q2 2014.

  • Cortex Capital Management reported no remaining Accretive Health position as of Q2 2014 after selling out during the quarter.
  • Cortex Capital Management sold 90,000 Accretive Health shares in Q2 2014, an estimated $720K.
  • Cortex Capital Management first reported a position in Accretive Health in Q1 2014 and held it in 1 quarter.
  • Cortex Capital Management's Accretive Health position peaked at $720K in Q1 2014.
  • 12 funds tracked by Wall St. Rank held Accretive Health as of Q2 2014.

Based on Cortex Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.